| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
10,650,000 |
| Market
Cap: |
1.25(M) |
| Last
Volume: |
1,291,850 |
Avg
Vol: |
1,288,294 |
| 52
Week Range: |
$0.1174 - $0.1174 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Laughlin Conan |
10% Owner |
– – • |
2016-03-15 |
4 |
B |
$1.21 |
$303,507 |
I/I |
250,460 |
12,849,000 |
1.5 |
- |
|
| Laughlin Conan |
10% Owner |
– – • |
2016-03-14 |
4 |
B |
$1.21 |
$119,499 |
I/I |
98,540 |
12,598,540 |
1.5 |
- |
|
| Varghese Santosh T |
Chief Medical Officer |
• – – |
2016-01-13 |
4 |
S |
$0.95 |
$1,475 |
D/D |
(1,553) |
102,220 |
|
- |
|
| Mohamed Johann Noor |
Interim CFO & Interim CAOOffic |
• – – |
2015-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
55,244 |
|
- |
|
| Roberts Eric W |
Director |
– • – |
2015-09-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,600 |
|
- |
|
| Varghese Santosh T |
VP, Medical & Reg Affairs |
• – – |
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
68,400 |
109,634 |
|
- |
|
| Fischer Seth H.z. |
Chief Executive Officer |
• • – |
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
117,000 |
186,080 |
|
- |
|
| Sanford Svai S |
Chief Financial Officer |
• – – |
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
62,800 |
128,359 |
|
- |
|
| Slebir John L |
SVP, Business Development & GC |
• – – |
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
76,000 |
139,584 |
|
- |
|
| Slebir John L |
SVP, Business Development & GC |
• – – |
2015-07-01 |
4/A |
S |
$2.20 |
$21,861 |
D/D |
(9,933) |
59,893 |
|
- |
|
| Varghese Santosh T |
VP, Medical & Reg Affairs |
• – – |
2015-07-01 |
4/A |
S |
$2.20 |
$18,738 |
D/D |
(8,514) |
35,373 |
|
- |
|
| Varghese Santosh T |
VP, Medical & Reg Affairs |
• – – |
2015-07-01 |
4 |
S |
$2.32 |
$18,326 |
D/D |
(7,899) |
41,234 |
|
- |
|
| Slebir John L |
SVP, Business Development & GC |
• – – |
2015-07-01 |
4 |
S |
$2.32 |
$21,379 |
D/D |
(9,215) |
63,584 |
|
- |
|
| Day Wesley |
VP, Clinical Development |
• – – |
2015-07-01 |
4 |
S |
$2.32 |
$18,284 |
D/D |
(7,881) |
49,118 |
|
- |
|
| Varghese Santosh T |
VP, Medical & Reg AffairsOffic |
• – – |
2015-04-28 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
43,887 |
|
- |
|
| Varghese Santosh T |
VP, Medical & Reg AffairsOffic |
• – – |
2015-04-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
49,133 |
|
- |
|
| Marsh Guy P |
VP, US Operations & GM |
• – – |
2015-01-29 |
4/A |
S |
$3.04 |
$1,924 |
D/D |
(633) |
30,854 |
|
- |
|
| Day Wesley |
VP, Clinical Development |
• – – |
2015-01-29 |
4 |
S |
$2.78 |
$1,312 |
D/D |
(472) |
56,999 |
|
- |
|
| Slebir John L |
SVP, Business Development & GC |
• – – |
2015-01-29 |
4 |
S |
$2.78 |
$1,751 |
D/D |
(630) |
72,799 |
|
- |
|
| Marsh Guy P |
VP, US Operations & GM |
• – – |
2015-01-29 |
4 |
S |
$2.78 |
$662 |
D/D |
(238) |
31,487 |
|
- |
|
| Sanford Svai S |
CFO & Chief Accounting Officer |
• – – |
2015-01-29 |
4 |
S |
$2.78 |
$1,312 |
D/D |
(472) |
65,559 |
|
- |
|
| Slebir John L |
SVP, Business Dev., GC |
• – – |
2015-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
25,900 |
73,429 |
|
- |
|
| Sanford Svai S |
CFO & Chief Accounting Officer |
• – – |
2015-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
25,300 |
66,031 |
|
- |
|
| Day Wesley |
VP, Clinical Development |
• – – |
2015-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
24,500 |
57,471 |
|
- |
|
| Fischer Seth H.z. |
Chief Executive Officer |
• • – |
2015-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
66,000 |
69,080 |
|
- |
|
555 Records found
|
|
Page 11 of 23 |
|
|
